|
|
||||||||
The Annals of Thoracic Surgery, Vol 37, 359-364, Copyright © 1984 by The Society of Thoracic Surgeons
TL Simon, BF Akl and W Murphy
Prophylactic administration of platelet concentrates to patients undergoing
their first cardiopulmonary bypass operation (coronary artery bypass
grafting or uncomplicated valve replacement) was evaluated in a controlled
randomized study of 28 patients. Four units of platelet concentrates
administered at the end of bypass prevented prolongation of the bleeding
time seen in patients not receiving platelets. However, chest tube blood
loss, transfusion requirements, and clinical outcome were not improved.
Moreover, thrombocytopenia and prolongation of bleeding time did not
correlate with blood loss or transfusion needs. Mild thrombocytopenia (to
58,000 platelets per microliter) and transient platelet dysfunction after
bypass do not require administration of platelet concentrates, and
prophylactic use of this blood component in the surgical setting of bypass
is not indicated.
ARTICLES
Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery
This article has been cited by other articles:
![]() |
A. P. Bode, R. M. Lust, M. S. Read, and T. H. Fischer Correction of the Bleeding Time With Lyophilized Platelet Infusions in Dogs on Cardiopulmonary Bypass Clinical and Applied Thrombosis/Hemostasis, January 1, 2008; 14(1): 38 - 54. [Abstract] [PDF] |
||||
![]() |
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Eckman, J. K. Erban, S. K. Singh, and G. S. Kao Screening for the Risk for Bleeding or Thrombosis Ann Intern Med, February 4, 2003; 138(3): W-15 - W-24. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Belcher, E. W. Muriithi, P. Wajon, and J. Gibson Postoperative Bleeding After Coronary Artery Bypass Surgery with Cardiopulmonary Bypass * Response Anesth. Analg., November 1, 2002; 95(5): 1466 - 1467. [Full Text] [PDF] |
||||
![]() |
N. J. Skubas and G. J. Despotis Optimal Management of Bleeding Complications After Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 217 - 228. [Abstract] [PDF] |
||||
![]() |
J.-O. Defraigne, J. Pincemail, G. Dekoster, R. Larbuisson, M. Dujardin, F. Blaffart, J.-L. David, and R. Limet SMA circuits reduce platelet consumption and platelet factor release during cardiac surgery Ann. Thorac. Surg., December 1, 2000; 70(6): 2075 - 2081. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Christiansen, J. Rotker, N. Roeder, U. R. Jahn, J. Stypmann, H. H. Scheld, and C. Schmid Are patients with Werlhof's disease at increased risk for bleeding complications when undergoing cardiac surgery? Eur. J. Cardiothorac. Surg., September 1, 2000; 18(3): 353 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Silvestry and P. K. Smith Current status of cardiac surgery in the abciximab-treated patient Ann. Thorac. Surg., August 1, 2000; 70(2): S12 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Despotis and L. T. Goodnough Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery Ann. Thorac. Surg., August 1, 2000; 70(2): S20 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Peterson, T. E. Hayes, C. F. Arkin, E. G. Bovill, R. B. Fairweather, W. A. Rock Jr, D. A. Triplett, and J. T. Brandt The Preoperative Bleeding Time Test Lacks Clinical Benefit: College of American Pathologists' and American Society of Clinical Pathologists' Position Article Arch Surg, February 1, 1998; 133(2): 134 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Despotis, J. H. Joist, and L. T. Goodnough Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes Clin. Chem., September 1, 1997; 43(9): 1684 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ray, BAppSc, N. A. Marsh, S. J. E. Just, BAppSc, E. J. Perrin, BAppSc, M. F. O'Brien, and G. A. T. Hawson Preoperative Platelet Dysfunction Increases the Benefit of Aprotinin in Cardiopulmonary Bypass Ann. Thorac. Surg., January 1, 1997; 63(1): 57 - 63. [Abstract] [Full Text] |
||||
![]() |
R. E. Helm, J. D. Klemperer, T. K. Rosengart, J. P. Gold, P. Peterson, W. DeBois, N. K. Altorki, S. Lang, S. Thomas, O. W. Isom, et al. Intraoperative Autologous Blood Donation Preserves Red Cell Mass But Does Not Decrease Postoperative Bleeding Ann. Thorac. Surg., November 1, 1996; 62(5): 1431 - 1441. [Abstract] [Full Text] |
||||
![]() |
P. O. Daily, J. A. Lamphere, W. P. Dembitsky, R. M. Adamson, and N. F. Dans Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass graftingA randomized, prospective, double-blind study J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 99 - 108. [Abstract] [Full Text] |
||||
![]() |
G. J. Despotis, S. A. Santoro, E. Spitznagel, K. M. Kater, J. L. Cox, P. Barnes, and D. G. Lappas Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 271 - 279. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |